Evidence map›Paper›PMID 40933456›Full record

ArticleWorld journal of gastroenterology2025

Incidence, disease course, therapeutic strategies and outcomes of inflammatory bowel disease-unclassified patients in Western Hungary: A population-based cohort.

Fruzsina Balogh, Lorant Gonczi, Dorottya Angyal, Petra Anna Golovics, Tunde Pandur, Gyula David, Zsuzsanna Erdelyi, Istvan Szita, Akos Ilias, Laszlo Lakatos and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Fruzsina BaloghDepartment of Gastroenterology, Central Hospital of Northern Pest-Military Hospital, Budapest 1062, Hungary.
Lorant GoncziThe First Department of Medicine, Semmelweis University, Budapest H-1083, Hungary.
Dorottya AngyalThe First Department of Medicine, Semmelweis University, Budapest H-1083, Hungary.
Petra Anna GolovicsDepartment of Gastroenterology, Central Hospital of Northern Pest-Military Hospital, Budapest 1062, Hungary.
Tunde PandurDepartment of Gastroenterology, Grof Eszterhazy Hospital, Pápa 8500, Hungary.
Gyula DavidDepartment of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem 8200, Hungary.
Zsuzsanna ErdelyiDepartment of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem 8200, Hungary.
Istvan SzitaDepartment of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem 8200, Hungary.
Akos IliasDepartment of Internal Medicine and Oncology, Semmelweis University, Budapest H-1083, Hungary.
Laszlo LakatosDepartment of Gastroenterology, Ferenc Csolnoky Hospital, Veszprem 8200, Hungary.
Peter Laszlo LakatosDepartment of Internal Medicine and Oncology, Semmelweis University, Budapest 1083, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe number of population-based studies on unclassified inflammatory bowel disease (IBD-U) is very limited.

aimTo evaluate the long-term incidence, disease course and surgery rates of IBD-U in a prospective population-based cohort.

methodsThe present study is a continuation of the well-established Veszprem IBD cohort with patient inclusion between 1977 and 2018. Both in-hospital and outpatient records were collected. The source of age- and gender-specific demographic data was derived from the Hungarian Central Statistical Office. Medical therapy, surgery and change in disease phenotype were analyzed.

resultsData of 119 incident IBD-U patients were analyzed [male/female: 55/64; median age at diagnosis: 34 years (interquartile range: 24-47.5)]. Adjusted mean incidence rate was 0.76 (95%CI: 0.63-0.9)/10

conclusionThese data extend our knowledge on the overall burden of IBD-U. Colonic involvement was extensive in a high proportion of IBD-U. Disease reclassification to Crohn's disease was relatively high. High rates of biological therapy and surgery rates support a relatively severe disease course of IBD-U.

Indexed as

Crohn DiseaseInflammatory Bowel DiseasesAdultDisease ProgressionFemaleFollow-Up StudiesHumansHungaryIncidenceMaleMiddle AgedProspective StudiesSeverity of Illness IndexTreatment OutcomeYoung AdultCrohn’s diseaseInflammatory bowel disease unclassifiedMedical therapyOutcomesPopulation-basedResective surgeryUlcerative colitis

Identifiers

PMID40933456
PMCPMC12417946

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.